Here is the full report of the 1970 National Fertility Study, a national sample survey for which thousands of women were interviewed who had been married at some time and were of reproductive age when they were interviewed. The book assesses the growth in the use of the pill and the IUD, the increasing reliance on contraceptive sterilization, and both the intended and the unwanted fertility of American women. The volume opens with an introduction to the survey and its methods. Contraceptive practice in 1970 is then compared with data for 1965, and an analysis is supplied of trends since 1955 in the attitudes of Roman Catholics. Originally published in 1977. The Princeton Legacy Library uses the latest print-on-demand technology to again make available previously out-of-print books from the distinguished backlist of Princeton University Press. These editions preserve the original texts of these important books while presenting them in durable paperback and hardcover editions. The goal of the Princeton Legacy Library is to vastly increase access to the rich scholarly heritage found in the thousands of books published by Princeton University Press since its founding in 1905.

A Chicago Tribune "Best Books of 2014" • A Slate "Best Books 2014: Staff Picks" • A St. Louis Post-Dispatch "Best Books of 2014" The fascinating story of one of the most important scientific discoveries of the twentieth century. We know it simply as "the pill," yet its genesis was anything but simple. Jonathan Eig's masterful narrative revolves around four principal characters: the fiery feminist Margaret Sanger, who was a champion of birth control in her campaign for the rights of women but neglected her own children in pursuit of free love; the beautiful Katharine McCormick, who owed her fortune to her wealthy husband, the son of the founder of International Harvester and a schizophrenic; the visionary scientist Gregory Pincus, who was dismissed by Harvard in the 1930s as a result of his experimentation with in vitro fertilization but who, after he was approached by Sanger and McCormick, grew obsessed with the idea of inventing a drug that could stop ovulation; and the telegenic John Rock, a Catholic doctor from Boston who battled his own church to become an enormously effective advocate in the effort to win public approval for the drug that would be marketed by Searle as Enovid. Spanning the years from Sanger’s heady Greenwich Village days in the early twentieth century to trial tests in Puerto Rico in the 1950s to the cusp of the sexual revolution in the 1960s, this is a grand story of radical feminist politics, scientific ingenuity, establishment opposition, and, ultimately, a sea change in social attitudes. Brilliantly researched and briskly written, The Birth of the Pill is gripping social, cultural, and scientific history.

The "contraceptive revolution" of the 1960s and 1970s introduced totally new contraceptive options and launched an era of research and product development. Yet by the late 1980s, conditions had changed and improvements in contraceptive products, while very important in relation to improved oral contraceptives, IUDs, implants, and injectables, had become primarily incremental. Is it time for a second contraceptive revolution and how might it happen? Contraceptive Research and Development explores the frontiers of science where the contraceptives of the future are likely to be found and lays out criteria for deciding where to make the next R&D investments. The book comprehensively examines today's contraceptive needs, identifies "niches" in those needs that seem most readily translatable into market terms, and scrutinizes issues that shape the market: method side effects and contraceptive failure, the challenge of HIV/AIDS and other sexually transmitted diseases, and the implications of the "women's agenda." Contraceptive Research and Development analyzes the response of the pharmaceutical industry to current dynamics in regulation, liability, public opinion, and the economics of the health sector and offers an integrated set of recommendations for public- and private-sector action to meet a whole new generation of demand.

In this book Hera Cook traces the path of sexuality in England, and shows how its route was determined by the gradual exertion of control over fertility. Most sexual activity had major economic and social costs, the most fundamental of which was the physical cost of children upon women's bodies. Around 1800 birth rates reached historical heights. Using a combination of demographic and qualitative sources, Dr Cook examines the connection between the struggle to lower fertility and the increasing repression of sexuality throughout the nineteenth century. Contraception became a viable option in the early twentieth century. The book charts the resulting slow relaxation of attitudes to sexuality and the remaking of heterosexual physical behaviour, culminating in the sexual revolution of the 1960s.

BIRTH CONTROL, CONTRACEPTION, FAMILY PLANNING. Heralded as the catalyst of the sexual revolution and the solution to global overpopulation, the contraceptive pill was one of the twentieth century's most important inventions. It has not only transformed the lives of millions of women but has also pushed the limits of drug monitoring and regulation across the world. This deeply-researched new history of the oral contraceptive shows how its development and use have raised crucial questions about the relationship between science, medicine, technology, and society. Lara Marks explores the reasons why the pill took so long to be developed and explains why it did not prove to be the social panacea envisioned by its inventors. Unacceptable to the Catholic Church, rejected by countries such as India and Japan, too expensive for women in poor countries, it has, more recently, been linked to cardiovascular problems.

As the first real contraceptive innovation in over 20 years, and as a long-acting method requiring clinical intervention for application and removal, the implantable contraceptive Norplant has raised a wide range of issues that could offer valuable lessons about the problems to be addressed if other new contraceptive technologies are to enter the marketplace. In April 1997 an Institute of Medicine workshop on implant contraceptives reviewed newly available data on Norplant's efficacy, safety, and use; identified lessons to be learned about the method's development, introduction, use, and market experience; and explored approaches to developing and introducing new contraceptives based on those lessons. This resulting book contains an examination of Norplant's efficacy and safety, its user populations, training for insertion and removal, consumer perspectives (quality of care, informed decisionmaking, and consumer involvement), and new approaches to contraceptive development and introduction. An appendix contains summaries of 17 workshop presentations.